Allergan Responds to Media Reports on Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
29 May, 2018: Patient safety is Allergan’s first priority. Allergan’s breast implants have been used for more than 40 years in more than 100 countries, including Australia.[1]
Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition
Allergan plc Completes Divestiture of Global Generics Business to Teva Pharmaceuticals